Child-resistant closure (CRC) systems for pharmaceutical bottles work on mechanical tolerances that are among the tightest in consumer packaging — tighter than standard beverage closures, tighter than aerosol valve assemblies, and significantly tighter than the general-purpose closure systems used in food packaging. The reason is functional: the push-and-turn or squeeze-and-turn mechanism that prevents a five-year-old from opening a medicine bottle relies on dimensional clearances measured in tenths of a millimeter. A container neck finish that is 0.2mm too wide in its outer thread diameter allows the closure sleeve to rotate without engaging the ratchet; a neck finish 0.2mm too narrow jams the sleeve and requires excessive torque to open. Both failure modes are regulatory non-conformances with field consequences. Understanding which machine parameters control each dimension — and whether the machine’s process capability is adequate for the tolerance — is the foundation for pharmaceutical bottle production on any ISBM platform.
01
CRC regulatory requirements and the performance tests that determine pass/fail
PPPA 16 CFR 1700, EN ISO 8317:2015, and the practical implications for container-closure testing
The US Poison Prevention Packaging Act of 1970 (PPPA) and its implementing regulations at 16 CFR Part 1700 established the first mandatory child-resistant packaging standard. Section 1700.20 defines the test protocol: 200 child subjects aged 42–51 months are recruited through a standardized screening process; each child is given the package with no instruction on how to open it and allowed 5 minutes of unassisted access; then the method of opening is demonstrated and a second 5-minute access attempt is allowed. The package passes the child-resistance test if fewer than 20% of the 200-child panel successfully open it within the total 10 minutes. A separate adult accessibility test uses 100 adult subjects aged 50–70 years, representative of older adults who may have reduced hand strength or dexterity; the package passes if ≥90% of this panel can open and re-close the package correctly within the specified time limit. The combined test — child resistance and adult accessibility — must be executed on the exact container-closure combination as it will be sold commercially. Testing one container design and applying the result to a geometrically similar design is not permitted without regulatory justification.
The EU standard EN ISO 8317:2015 (Packaging — Child-resistant packaging — Requirements and testing procedures for reclosable packages) applies the same child panel and adult accessibility test methodology as PPPA with marginally different pass criteria: ≤15% of children open the package (stricter than PPPA’s <20%) and ≥90% of adults open it within 1 minute with instructions (PPPA requires 5 minutes without an explicit time cap on the adult test in all configurations). The practical significance of the EN ISO 8317 child criterion being stricter is that a container-closure combination that narrowly passes PPPA may fail EN ISO 8317 — a relevant consideration for pharmaceutical products seeking simultaneous US and EU market approval with a single container-closure system.
The mechanics of why neck finish dimensions determine CRC performance are specific to the closure mechanism. A push-and-turn (P&T) CRC operates by compressing a spring-loaded internal ratchet when the closure cap is pushed downward; this compression disengages the ratchet teeth from the container thread and allows the cap to rotate. The downward displacement required to disengage the ratchet is controlled by the H-dimension of the neck finish (the height from the seating surface to the top of the neck thread) — if H is too short, the ratchet disengages with minimal force, reducing child resistance; if H is too tall, the adult user must apply excessive downward force before rotation is possible, potentially failing the adult accessibility test. The force required to rotate the cap (after ratchet disengagement) is controlled by the thread clearance — which depends on the T-dimension of the neck finish relative to the inner diameter of the closure sleeve. The thread lead angle and pitch, both set by the mold tooling geometry, determine how the rotational torque translates to axial movement during opening. The seating surface flatness (S-dimension) controls how evenly the closure liner seals against the container opening — critical for both leakage prevention and for the torque uniformity that the adult panel experiences when re-closing.
| Standard | Geography | Child resistance pass criterion | Adult accessibility pass criterion | Re-test trigger |
|---|
| 16 CFR 1700.20 (PPPA) | USA | <20% of 200 children aged 42–51 months open within 10 minutes total | ≥90% of 100 adults aged 50–70 open and re-close correctly | Any change to container neck geometry, closure geometry, or closure supplier lot |
| EN ISO 8317:2015 | EU / Global | ≤15% of 200 children aged 42–51 months open (stricter than PPPA) | ≥90% of 100 adults aged 50–70 open within 1 minute with instructions | Any change to container-closure system as tested; design equivalence must be scientifically justified |
02
The four neck finish dimensions and their machine control paths
T, E, H, and S dimensions — which machine parameter controls each, and what out-of-tolerance looks like in production
All four CRC-critical neck finish dimensions are formed at the injection station of the ISBM machine — not at the blow station. This is an important distinction that is sometimes missed by process engineers more familiar with two-step blow molding: in the one-step ISBM process, the neck finish geometry is established during the injection phase and is not modified during the stretch blow phase. The blow station stretches the preform body and base; the neck and the thread are already formed in their final geometry when the injection mold opens. Machine parameters at the blow station (blow pressure, conditioning temperature, stretch rod timing) do not affect neck finish T, E, H, or S dimensions — these are injection station variables exclusively.
T-DIM
Outer neck thread diameter — tolerance ±0.10mm for CRC; ±0.15mm for standard closures
The T-dimension is the outer diameter of the neck finish thread, measured at the major diameter of the thread form. For standard pharmaceutical bottle closures (non-CRC), the T-dimension tolerance is ±0.15mm, and for CRC closures it is tightened to ±0.10mm — because the ratchet engagement clearance in a CRC is smaller than the thread clearance in a standard continuous-thread closure, so the same dimensional variation has a larger functional effect. T is primarily controlled by the injection mold cavity diameter at the thread zone and the injection holding pressure. Higher holding pressure packs more material into the thread cavity, increasing T; lower holding pressure allows the molten PET to shrink away from the thread cavity, decreasing T. On the HGA.ES series, injection holding pressure is controlled by the servo-driven injection axis to ±1% of set point, which translates to T-dimension cycle-to-cycle variation of approximately ±0.012–0.018mm (σ) — well within the Cpk 1.33 requirement for the ±0.10mm CRC tolerance.
Out-of-tolerance symptom: T oversized → CRC sleeve binds on closure application; torque required to open exceeds adult panel capacity; adult accessibility failure. T undersized → CRC sleeve rotates freely without ratchet engagement; child-resistance failure; closure may also leak at seating surface.
E-DIM
Neck seating surface outer diameter — tolerance ±0.10mm
The E-dimension is the outer diameter of the neck at the seating surface — the flat annular ring immediately below the thread start that the closure liner compresses against to create a seal. The E-dimension controls both the radial position of the closure liner against the container wall and the compression force distribution around the circumference of the seal. For CRC closures with an inner foam or wadding liner, the E-dimension determines whether the liner is compressed against the container seating surface or whether it rides above the surface — the latter allows the closure to appear locked while leaving a leak path between the liner and the container. E-dimension control relies on the same injection holding pressure as T-dimension, with an additional sensitivity to cooling water temperature at the neck core insert: if the neck insert runs warm (above 15°C water temperature), the PET at the seating surface zone retains heat and continues to shrink after mold opening, reducing the effective E-dimension below the molded value. Cooling water flow rate at the neck insert should be confirmed at ≥8 ltr/min dedicated circuit for pharmaceutical production.
Out-of-tolerance symptom: E oversized → liner over-compressed; excessive closing torque; CRC engagement depth reduced (functional failure). E undersized → liner under-compressed; seal leak; also — if E is below the closure’s minimum engagement diameter, the CRC lock mechanism does not properly engage its lower stop, and the closure can be removed with a pulling force without rotational engagement.
H-DIM
Neck finish height — tolerance ±0.15mm
The H-dimension is the total height of the neck finish from the container seating surface to the top of the neck opening. For CRC push-and-turn closures, H controls the downward displacement of the closure before ratchet disengagement — and therefore the child resistance force level. If H is shorter than the nominal specification (a condition produced by short-shot injection, insufficient holding time, or excessive post-mold shrinkage), the closure’s internal ratchet disengages at lower downward force — effectively reducing the push force required to initiate rotation and compromising the child resistance mechanism. If H is taller than nominal (produced by over-holding at injection or by flash formation at the top of the neck), the ratchet disengages only at higher downward force — which may cause elderly or arthritic users to fail the adult accessibility test. H-dimension control depends on the injection holding time and holding pressure in combination: holding pressure determines packing level; holding time determines the duration over which the material is constrained in the mold before the gate freezes and the screw can begin recovery. On the HGA.ES series, holding time and holding pressure are each independently programmable in 1-unit increments (ms for time, 0.1 kg/cm² for pressure), allowing precise tuning of the H-dimension.
Out-of-tolerance symptom: H too short → reduced push force required for CRC engagement → risk of child-resistance failure on panel testing. H too tall → excessive adult opening force → risk of adult accessibility failure, particularly for elderly panel members with reduced grip and hand strength.
S-DIM
Seating surface flatness — tolerance ±0.08mm (tightest CRC specification)
The S-dimension is technically a form tolerance rather than a linear dimension — it is the flatness deviation of the annular seating surface (the land below the thread start) measured across its full width. For CRC pharmaceutical bottles, the seating surface flatness tolerance of ±0.08mm is the most demanding of the four neck finish specifications, because any deviation from true flat creates a high point on one side of the circumference and a low point on the opposite side — and the closure liner, which is compliant (foam or wadding), preferentially conforms to the high point, leaving a gap at the low point through which the liquid pharmaceutical product can leak. On a squeeze-and-turn (S&T) CRC, the seating surface flatness requirement is even tighter (typically ±0.06mm), because the inward squeeze force during opening and closing creates an asymmetric moment on the seating surface that amplifies any pre-existing flatness deviation. Seating surface flatness is primarily controlled by the uniformity of the injection holding pressure across the gate — if the injection gate is partially obstructed (a common occurrence with contaminated preform resin or a partially blocked hot-runner nozzle), the holding pressure is non-uniform around the neck circumference, producing a systematically out-of-flat seating surface. On the HGA.ES series, the injection gate pressure profile is monitored by cavity pressure transducers (optional but recommended for pharmaceutical production) and any cavity pressure deviation above the set-point threshold triggers an alarm and mold reject.
Out-of-tolerance symptom: Out-of-flat seating surface → non-uniform liner compression → liquid pharmaceutical leaks at the low point of the seating surface circumference, typically most visible when the filled bottle is inverted. Leak events on filled pharmaceutical products typically trigger a batch investigation and potentially a field CAPA — the seating surface flatness specification should be verified on every production run first article.
±0.08mm
Seating surface flatness (S)
Tightest CRC neck finish specification — controlled by injection holding pressure uniformity
1.85–2.20
Cpk achievable (T-dim, HGA.ES servo)
σ ≈ 0.012–0.018mm; required Cpk ≥ 1.33 at PQ for pharmaceutical GMP
0.8–1.1
Cpk typical (hydraulic drive, T-dim)
Hydraulic fluid temperature drift 3–5% over shift; clamping force shifts; T-dim drifts outside CRC tolerance
Technical Information on CRC Child-Resistant Caps and Bottle Neck Precision Control
03
In-process inspection and statistical process control for CRC neck finish dimensions
Gauge selection, sampling plan, and SPC chart setup for pharmaceutical GMP bottle production
The measurement system for CRC neck finish dimensions must itself pass a Gauge Repeatability and Reproducibility (Gauge R&R) study before it can be used to generate the process capability data required for PQ. A gauge R&R study for neck finish dimensions uses 3 operators × 2 replicates × 10 containers; the total measurement system variation (gauge R&R) expressed as a percentage of the tolerance band must be below 10% for the gauge to be qualified for pharmaceutical GMP production use. For the T-dimension with a ±0.10mm (total 0.20mm) tolerance, a gauge R&R of 10% means the measurement system may contribute up to 0.020mm of variation to the total measured variation — which for a process with σ ≈ 0.015mm (the typical HGA.ES servo performance) represents a non-trivial measurement contribution. Digital neck gauges with resolution ≤0.001mm and calibration uncertainty ≤0.005mm (traceable to NIST, NPL, or PTB) typically pass the gauge R&R requirement for CRC pharmaceutical neck finish measurement with ample margin.
The SPC chart setup for pharmaceutical CRC bottle production uses X-bar/R (or X-bar/S) control charts with control limits set at ±3σ — which is the natural process variation, not the specification tolerance. The distinction is operationally important: control limits based on ±3σ from the process mean trigger investigation before the specification tolerance is approached; control limits based on the specification tolerance (±0.10mm for T-dimension) only alert the operator after the process is already producing potentially out-of-specification containers. For a process with σ = 0.015mm, ±3σ control limits are ±0.045mm from the process mean — meaning the control chart alerts at ±0.045mm from target, while the specification tolerance is ±0.10mm. This gives a 0.055mm “warning band” inside the specification, which is the early warning that allows investigation and correction before out-of-specification containers are produced.
The sampling frequency for CRC pharmaceutical bottle production during the PQ phase is: 5 containers per cavity per hour, measured for all four CRC dimensions (T, E, H, S), with control chart updates at each measurement interval. During steady-state production after PQ, the sampling frequency may be reduced to 5 containers per cavity per 2 hours if the process has demonstrated statistical control across the entire PQ period and a minimum of 3 weeks of subsequent production. Any SPC out-of-control signal (a single point outside ±3σ, 2 of 3 consecutive points outside ±2σ, or 8 consecutive points on one side of the centerline) triggers: (1) production stop; (2) measurement of 10 consecutive containers from all cavities; (3) if all 10 are within specification, investigation of assignable cause and production resumption with enhanced monitoring; (4) if any of the 10 is outside specification, quarantine of all containers since last confirmed in-specification check, initiation of deviation investigation per site QA procedure, and root cause analysis before resuming production.
1
Gauge R&R qualification before PQ
3 operators × 2 replicates × 10 containers for T and E dimensions. Total measurement system variation <10% of tolerance band (i.e., <0.020mm for ±0.10mm tolerance). Digital neck gauges with resolution ≤0.001mm and calibration uncertainty ≤0.005mm (NIST/NPL/PTB traceable). Re-verify gauge R&R annually and after any gauge replacement or repair.
2
SPC control limit setup
Control limits at ±3σ from process mean (process variation, not tolerance). For HGA.ES servo at σ = 0.015mm: control limits = ±0.045mm from target. This leaves a 0.055mm early-warning band inside the ±0.10mm CRC specification tolerance. Charts: X-bar/R for subgroup size n=5 per cavity per sampling interval.
3
PQ phase sampling frequency
5 containers per cavity per hour, all four CRC dimensions (T, E, H, S). After PQ and 3 weeks of demonstrated statistical control in steady-state production: reduce to 5 containers per cavity per 2 hours. Seating surface flatness (S-dim) check via optical flatness tester or precision height gauge — reduce sampling frequency only after demonstrated stability of the injection holding pressure and gate condition.
4
Out-of-control response and documentation
Any SPC signal: stop production → measure 10 consecutive containers (all cavities) → assess against specification → quarantine or resume with enhanced monitoring → document decision and rationale in batch record → attach measurement data to the deviation record if out-of-specification. Root cause analysis mandatory before production resumes after an out-of-specification finding.
04
Frequently asked questions
How long does the CRC child-resistance testing protocol take from container-closure submission to final test report? ＋
At accredited testing facilities in the US and EU, the total timeline from container-closure sample submission to final signed test report is typically 10–16 weeks. The child panel recruitment (200 children aged 42–51 months through a standardized screening process) requires 4–8 weeks alone; adding scheduling, actual test execution, data analysis, and report review, the full timeline is 10–16 weeks from sample receipt to report delivery. This timeline should be built into the pharmaceutical product development schedule — ideally the CRC test container-closure combination is submitted for testing during the product stability study phase, so the test result is available before the regulatory submission package is finalized. A common project management error is to assume the CRC test can be executed in parallel with the final dossier compilation — if the test fails and the container-closure combination must be modified, the regulatory submission is delayed until a new container-closure combination is re-tested, which adds another 10–16 weeks to the timeline.
What is the practical difference between push-and-turn and squeeze-and-turn CRC in terms of neck finish tolerance requirements? ＋
Push-and-turn (P&T) CRCs engage by compressing a spring-loaded ratchet with downward force before rotation is possible. The critical dimensions for P&T are H (controls the downward displacement required to disengage the ratchet — the child resistance mechanism), T (controls the rotational clearance after disengagement), and S (controls liner seal integrity). Squeeze-and-turn (S&T) CRCs engage by applying inward force (thumb and forefinger) that depresses spring-loaded locking tabs on the outer sleeve before rotation is possible. For S&T, the E-dimension and S-dimension (seating surface flatness) are more critical than for P&T, because the inward squeeze force creates a bending moment on the container neck that amplifies any existing flatness deviation at the seating surface — an S-dim of ±0.08mm that is acceptable for P&T may produce visible seating surface distortion under S&T squeeze force. Accordingly, S&T CRC applications typically require seating surface flatness ±0.06mm rather than ±0.08mm. Before specifying which CRC type to use, confirm the specific neck finish dimensional requirements from the closure supplier — and if switching from P&T to S&T on the same neck finish geometry, verify seating surface flatness against the tighter ±0.06mm requirement on a qualification batch before committing to commercial production.
Does changing the mold supplier for the same neck finish specification require a new CRC performance test? ＋
Changing the mold supplier for the container — even if the new mold is specified to the identical T, E, H, S dimensional requirements — is typically treated as a potential design change that requires at minimum a documented dimensional equivalence study and potentially a new CRC test. The reason is that mold tooling from different suppliers, even built to the same nominal specification, may differ in thread lead angle, thread root radius, seating surface surface roughness, and other secondary geometric parameters that affect the torque-displacement profile of the CRC mechanism without changing the four primary dimensions. These secondary parameters are not routinely measured in production quality control. If the new tooling produces containers where any of these secondary parameters differ from the original tooling, the CRC torque-displacement profile changes, and the child panel result for the new container-closure combination may differ from the original test result — even if the new containers pass the dimensional specification for T, E, H, and S. Before switching mold tooling suppliers, confirm the CRC test status with the regulatory authority — some authorities accept a documented dimensional equivalence study and functional comparison (closing torque, opening torque at adult panel age-specific hand strength range) as sufficient; others require a full re-test.
Specifying a CRC-compatible pharmaceutical bottle production line?
Share your CRC closure type (P&T or S&T), neck finish dimensions, target Cpk, and container volume — receive an HGA.ES model recommendation with neck finish process capability data and SPC setup guidance.
View HGA medicine bottle machine range →
